Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

MedStar Heart Institute and Infraredx, Inc Initiate the Lipid Rich Plaque (LRP) Study to Evaluate Prediction of Heart Attacks

October 31, 2013 9:57 am | by Business Wire | News | Comments

MedStar Heart Institute of Washington, D.C. and Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced the initiation of the Lipid-Rich Plaque (LRP) Study...

First Aid Teams Set to Improve Heart Attack Survival with Pocket Manual

October 31, 2013 9:30 am | by European Society of Cardiology (ESC) | News | Comments

First aid teams are set to improve the survival of heart attack patients with the first pocket-sized manual on acute cardiac conditions. The toolkit was created by expert members of the Acute Cardiovascular Care Association (ACCA) of the European Society of Cardiology (ESC) to help ...

Evaluating Live 3D Holographic Imaging in Interventional Cardiology

October 31, 2013 9:25 am | by Philips | News | Comments

Royal Philips and RealView Imaging Ltd. today announced that they have completed a clinical study that has demonstrated the feasibility of using an innovative live 3D holographic visualization and interaction technology to ...    

Advertisement

Debiotech and AWAK Enter into Joint Agreement for the Development and Manufacturing of a Novel Miniaturized Home Hemodialysis Machine

October 31, 2013 8:45 am | by PR Newswire | News | Comments

Debiotech SA, Switzerland, and AWAK Technologies Pte Ltd., Singapore, announced today that they have entered into a partnership agreement regarding the development and manufacturing of a novel miniaturized Home Hemodialysis machine...

Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve Novolimus Eluting Coronary Scaffold System

October 31, 2013 7:00 am | by Business Wire | News | Comments

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced excellent one-year results from the DESolve Nx international pivotal clinical trial for the CE...  

New Study Compares Provisional & Two-Stent Strategies for Coronary Bifurcation Lesions

October 30, 2013 4:10 pm | by Cardiovascular Research Foundation | News | Comments

A new clinical trial shows that a two-stent technique for treatment of bifurcation lesions with a large stenotic side branch was not associated with significant improved outcomes compared to a provisional stenting approach. The findings from the Nordic-Baltic Bifurcation IV study were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics scientific symposium.

First Aid Teams Set to Improve Heart Attack Survival with Pocket Manual

October 30, 2013 4:05 pm | by European Society of Cardiology | News | Comments

First aid teams are set to improve the survival of heart attack patients with the first pocket-sized manual on acute cardiac conditions. The toolkit was created by expert members of the Acute Cardiovascular Care Association of the European Society of Cardiology to help first aid teams across Europe make the best decisions in seconds after a heart attack.

Medtronic claims a win in European patent row with Edwards Lifesciences

October 30, 2013 10:58 am | by Mass Device | News | Comments

Medtronic is claiming a win in Europe in its patent row with Edwards Lifesciences over their competing transcatheter aortic valve implants. The European Patent Office issued a preliminary, non-binding ruling that the Edwards patent at the center of a...

Advertisement

OrbusNeich's COMBO Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes Out to 24 Months

October 29, 2013 5:58 pm | by PR Newswire | News | Comments

OrbusNeich has announced that new clinical data presented at TCT 2013 show durable outcomes as well as excellent early healing and optimal neointimal suppression out to 24 months following placement of the COMBO Dual Therapy Stent.  

Medtronic CoreValve U.S. Pivotal Trial Results Reveal Positive Outcomes for Patients

October 29, 2013 2:25 pm | by Medtronic | News | Comments

Medtronic, Inc. today announced the highly anticipated results from the CoreValve U.S. Pivotal Trial, the first U.S. data presented on the Medtronic CoreValve® System. The study of the novel self-expanding device, presented at a late-breaking...

Data: Significant and Sustained Blood Pressure Reduction with Boston Scientific’s Renal Denervation System

October 29, 2013 11:37 am | by PR Newswire | News | Comments

Patients treated with the Boston Scientific Vessix Renal Denervation System experienced a significant and sustained reduction in blood pressure, according to new data presented today at the Transcatheter Cardiovascular Therapeutics (TCT)...

Reverse Medical Corporation Announces Regulatory Approvals for Its Microcatheters for Neurovascular Indications

October 29, 2013 6:15 am | by Business Wire | News | Comments

Reverse Medical Corporation today announced CE Mark approval, FDA 510k clearance and initial clinical use of their ReVerse Microcatheter product line for intracranial neurovascular use. The device has been granted European Union CE Mark...

St. Jude Medical Reports Positive Clinical Outcomes from Portico Heart Valve Study

October 28, 2013 9:37 pm | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced positive results for the 23 and 25 mm Portico Transcatheter Aortic Heart Valves in the Portico Transfemoral CE Mark Trial. Patients enrolled in the study experienced a...

Advertisement

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented

October 28, 2013 9:22 pm | by Business Wire | News | Comments

St. Jude Medical, Inc., a global medical device company, today announced new results from the EnligHTN I study, confirming safe, rapid and sustained reduction in blood pressure measurements a year and a half post-procedure. Data presented at...

TCT 2013: Higher pacemaker rate marks difference between Medtronic's, Edwards Lifesciences' TAVI devices

October 28, 2013 6:28 pm | by Mass Device | News | Comments

Results from the PRAGMATIC Plus analysis of Edwards Lifesciences' Sapien transcatheter aortic valve implantation system and Medtronic's rivaling CoreValve device found few differences between the devices, with the exception of lower rates of...

TCT 2013: Renal denervation does everything

October 28, 2013 4:35 pm | by Mass Device | News | Comments

Renal denervation may have lost some of its hype over the course of the last year, but researchers are still findings new ways to utilize the technology to target new diseases. Technologies such as Medtronic's Symplicity and St. Jude Medical's...

Boston Scientific Receives CE Mark for Lotus Valve System

October 28, 2013 2:09 pm | by PR Newswire | News | Comments

Boston Scientific Corporation has received CE Mark for the Lotus™ Valve System, the company's advanced transcatheter aortic valve replacement (TAVR) technology.  This key approval offers a unique and effective new treatment alternative for...

Photos of the Day: Biology in 3D

October 28, 2013 11:31 am | by NIH | News | Comments

Using a new type of microscopy developed in the High Resolution Optical Imaging lab at the National Institute of Biomedical Imaging and Bioengineering, researchers in Hari Shroff's lab are able to view individual blood cells moving through a live...

New Microscopes Reveal Live, Developing Cells in Unprecedented 3D Clarity

October 28, 2013 11:08 am | by NIH | News | Comments

Researchers at NIH have developed two new microscopes, both the first of their kind. The first captures small, fast moving organisms at an unprecedented rate and the second displays large cell samples in three dimensions while decreasing the...

Mount Sinai Cardiologist First in U.S. to Use CSI’s New Technology to Treat Coronary Artery Disease

October 28, 2013 8:00 am | by Business Wire | News | Comments

Cardiovascular Systems, Inc. announced that Samin K. Sharma, M.D., Director of Clinical and Interventional Cardiology at The Mount Sinai Medical Center, New York, N.Y., is the first physician in the United States to treat severely calcified coronary...

Middle Peak Medical Raises an Additional $3M to Develop Novel Mitral Valve Technology

October 28, 2013 5:00 am | by PR Newswire | News | Comments

Middle Peak Medical, a development-stage medical device company that will commercialize a novel technology for treating mitral valve disease, has raised an additional $3M in a second closing of its over-subscribed Series A financing, which now...

'High-Risk' Organs Safe When Screened with Current Methods

October 25, 2013 11:46 am | by American Society of Nephrology | News | Comments

Approximately 10% of deceased donor kidneys are considered "high-risk" for infection (HIV, HCV, HBV) and disease transmission according to criteria set by the Centers for Disease Control and Prevention. But new research suggests that many of...

Abbott's First-In-Class MitraClip Device Available for U.S. Patients

October 25, 2013 9:05 am | by The Associated Press | News | Comments

Abbott today announced that its first-in-class, catheter-based MitraClip therapy has received U.S. Food and Drug Administration (FDA) approval and will launch immediately in the United States, providing physicians with a breakthrough treatment...

3D Vessel Reconstruction Technology to Aid Physicians in Stent Placement

October 24, 2013 3:41 pm | by St. Jude Medical | News | Comments

St. Jude Medical has announced U.S. Food and Drug Administration (FDA) approval and launch of its ILUMIEN™ OPTIS™ PCI Optimization™ System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with ...

Study: Strokes Affecting More Younger People

October 24, 2013 1:41 pm | by Maria Cheng, AP Medical Writer | News | Comments

Strokes are increasingly hitting younger people and the incidence of the crippling condition worldwide could double by 2030, warns the first global analysis of the problem. Though the chances of a stroke jump dramatically with ...  

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading